I think the market has spoken in regard to the minimum value of our PSI-GAD program
Big Pharma buying Mindset for USD$60M for Pre-Clinical Psychedelics https://bit.ly/484ASQ6
PSI-GAD is far more advanced of course. >> Approaching completion of Phase 2 Study at Monash >> Developing IND Filing Application for the FDA >> Joel confirms for a Blended Phase 2/3 Trial in the USA
Add the Clarion Clinics Business into the mix, what's it worth?